Biotech and Alternative Energy stocks will see massive gains. Why? Biotech: The Obama administration will put aside silly restrictions on biotech research. Alternative Energy: The Obama administration will fund, massively, truly fundamental research on alternative energy and pass tax policies favorable to these corporations. Incompetent policies espousing energy independence such as Ethanol and "turn off the light" are now officially out the door. I don't have any personal favorites at the moment. I will wait until actual policies are unveiled before posting picks.
April 22, 2009 12:09 PM EDT Wedbush Morgan reiterates a 'Buy' on Gilead Sciences (Nasdaq: GILD). Price target increased from $56 to $58. Wedbush analyst says, "Gilead reported Q1:09 total revenue of $1.53 billion and EPS of $0.63 versus our $1.52 billion and $0.60 and Street of $1.50 billion and $0.59, respectively. Total antiviral revenue was $1.34 billion versus our $1.34 billion and Street of $1.33 billion, respectively. We see future HIV sales growth being driven by a shift in treatment guidelines towards earlier initiation of therapy. Phase II study of elvitegravir âquadâ regimen enrolling quickly." http://www.streetinsider.com/Analys...nces+(GILD);+Raises+Price+Target/4579993.html